Invitae Company

Invitae's mission is to bring genetics to mainstream medicine to improve healthcare for billions. Invitae’s medical-grade genetic testing analyzes genes to find changes that can potentially lead to disease. The range of testing specialization includes Pregnancy, Staying Healthy, Cancer, Genetic Illness. Their pre-pregnancy genetic testing and diagnostics services intends to set new standard of care for genetic screening of inherited disorders.
Industry: Longevity
Headquarters: San Francisco, California, United States
Founded Date: 01-01-2010
Employees Number: 501-1000
Funding Status: IPO
Acquisitions Number: 14
Investors Number: 16
Total Funding: $1,989,502,111
Estimated Revenue: $100M to $500M
Last Funding Date: 2021-04-05
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership